These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16730498)

  • 1. Endometrial histology, microvascular density and caliber, and matrix metalloproteinase-3 in users of the Nestorone-releasing contraceptive implant with and without endometrial breakthrough bleeding.
    Oliveira-Ribeiro M; Petta CA; De Angelo Andrade LA; Hidalgo MM; Pellogia A; Bahamondes L
    Contraception; 2006 Jun; 73(6):634-40. PubMed ID: 16730498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system.
    Oliveira-Ribeiro M; Petta CA; De Angelo Andrade LA; Bahamondes L; Hidalgo MM
    Hum Reprod; 2004 Aug; 19(8):1778-84. PubMed ID: 15192067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels.
    Hickey M; Doherty DA; Fraser IS; Sloboda DM; Salamonsen LA
    Hum Reprod; 2008 Apr; 23(4):912-8. PubMed ID: 18216041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding.
    Rogers PA; Martinez F; Girling JE; Lederman F; Cann L; Farrell E; Tresserra F; Patel N
    Hum Reprod; 2005 Dec; 20(12):3341-7. PubMed ID: 16085661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women.
    Morison NB; Zhang J; Kaitu'u-Lino TJ; Fraser IS; Salamonsen LA
    Reproduction; 2007 Jan; 133(1):309-21. PubMed ID: 17244756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial histology of Depomedroxyprogesterone acetate users: a pilot study.
    Thurman AR; Soper DE
    Infect Dis Obstet Gynecol; 2006; 2006():69402. PubMed ID: 17093355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Stéphanie R; Labied S; Blacher S; Frankenne F; Munaut C; Fridman V; Beliard A; Foidart JM; Nisolle M
    Hum Reprod; 2007 Dec; 22(12):3084-91. PubMed ID: 17921480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women.
    Sivin I; Croxatto H; Bahamondes L; Brache V; Alvarez F; Massai R; Schechter J; Ranta S; Kumar N; Wu E; Tejeda AS; Reyes V; Travers E; Allen A; Moo-Young A
    Contraception; 2004 Feb; 69(2):137-44. PubMed ID: 14759619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding.
    Zhang X; Qi C; Lin J
    Fertil Steril; 2010 May; 93(7):2362-7. PubMed ID: 19249761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
    Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
    Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system.
    Peloggia A; Petta CA; Bahamondes L; Oliveira-Ribeiro M; Zhang J; Salamonsen L
    Hum Reprod; 2006 May; 21(5):1129-34. PubMed ID: 16436495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant.
    Zhao S; Choksuchat C; Zhao Y; Ballagh SA; Kovalevsky GA; Archer DF
    Contraception; 2009 Jun; 79(6):469-78. PubMed ID: 19442784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users.
    Marbaix E; Vekemans M; Galant C; Rigot V; Lemoine P; Dubois D; Picquet C; Henriet P; Twagirayezu P; Sufi S; Eeckhout Y; Courtoy PJ
    Hum Reprod; 2000 Aug; 15 Suppl 3():120-34. PubMed ID: 11041228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mifepristone on endometrial matrix metalloproteinase expression and leukocyte abundance in new medroxyprogesterone acetate users.
    Li A; Felix JC; Yang W; Xiong DW; Minoo P; Jain JK
    Contraception; 2007 Jul; 76(1):57-65. PubMed ID: 17586139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial effects of intrauterine levonorgestrel.
    Guttinger A; Critchley HO
    Contraception; 2007 Jun; 75(6 Suppl):S93-8. PubMed ID: 17531624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy.
    Chegini N; Luo X; Pan Q; Rhoton-Vlasak A; Archer DF
    Hum Reprod; 2007 Feb; 22(2):427-33. PubMed ID: 17095519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological characteristics and altered expression of interleukins (IL) IL-13 and IL-15 in endometria of levonorgestrel users with different uterine bleeding patterns.
    Rhoton-Vlasak A; Chegini N; Hardt N; Williams RS
    Fertil Steril; 2005 Mar; 83(3):659-65. PubMed ID: 15749495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
    Rogers PA; Au CL; Affandi B
    Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-dimensional study of endometrial microvessels in women using the contraceptive subdermal levonorgestrel implant system, norplant.
    Simbar M; Manconi F; Markham R; Hickey M; Fraser IS
    Micron; 2004; 35(7):589-95. PubMed ID: 15219905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.